Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy. - Burchard PR; Ruffolo LI; Ullman NA; Dale BS; Dave YA; Hilty BK; Ye J; Georger M; Jewell R; Miller C; De Las Casas L; Jarolimek W; et al. (Hepatology communications, 2024)